期刊文献+

渗出型老年性黄斑变性重复光动力疗法的临床观察 被引量:7

Clinical observation on repetitive photodynamic therapy for exudative age-related macular degeneration
原文传递
导出
摘要 目的总结2002年7月至2005年3月光动力疗法(PDT)治疗渗出型老年黄斑变性(AMD),重复治疗病例的疗效和临床特点。方法回顾分析渗出型AMD患者78例94只眼采用PDT治疗,患者平均年龄68.4岁,治疗次数为132次,平均1.4次,其中22例30只眼接受重复PDT治疗,占治疗总数31.9%。30只眼共进行PDT治疗68次,其中2次22只眼,占73.3%;3次7只眼,占23.3N;6次1只眼,占3.3%。随诊时间3~32个月,平均随诊时间16.7个月。结果PDT治疗后末次随诊检查时,荧光素眼底血管造影(FFA)或FFA联合吲哚青绿血管造影(ICGA)检查显示CNV渗漏停止14只眼,占46.7%;渗漏减少12只眼,占40%;持续渗漏4只眼,占13.3%。与首次PDT治疗前相比,末次检查矫正视力提高≥2行7只眼,占23.3%;视力波动在上下1行以内14只眼,占43.3%;视力下降≥2行9只眼,占30%。首次PDT后最佳矫正视力13只眼视力提高≥2行,占43.3%;12只眼视力波动在上下1行之内,占40%;5只眼视力下降≥2行,占16.7%。在随诊期中,最佳矫正视力出现在首次PDT后24只眼,占80%;有5只眼出现在2次PDT后,占16.7%;1只眼出现在3次PDT后,占3.3%。结论在重复PDT治疗患者中,末次随诊检查大部分眼CNV能完全或部分闭合,视力提高和维持者占67.8%,最佳矫正视力多出现在首次PDT后,随着PDT治疗次数的增加,最佳矫正视力出现的概率减小。 Objective To summarize the therapeutic effect and clinical characteristics of repetitive photodynamic therapy (PDT) for patients with exudative age-related macular degeneration (AMD). Methods The clinical data from 78 patients (94 eyes) with exudative AMD who had undergone PDT from July, 2002 to March, 2005 were retrospectively analyzed. The average age of the patients was 68.4, and the treated times was 132 (mean 1.4). Thirty eyes underwent PDT 68 times, including twice in 22 eyes (73.3%), 3 times in 7 eyes (23.3%), and 6 times in 1 eye (3.3%). The follow-up period lasted 3-32 months with the average of 16. 7 months. Results In the final follow-up examination, the results of fundus fluorescein angiography or combined with indocyanine green angiography showed that the leakage of choroidal neovascularization (CNV) stopped in 14 eyes (46.7%), reduced in 12 (40%), and remained in 4 (13.3%). Compared with the condition before first PDT, the correct visual acuity increased ≥2 lines in 7 eyes (23.3%), changed ±1 line in 14 eyes (43.3%), and decreased ≥2 lines in 9 eyes (30%) in the final examination. After first PDT, the best corrected visual acuity increased ≥2 lines in 13 eyes (43.3%), changed ±1 line in 12 eyes (40%), and decreased ≥2 lines in 5 eyes (16. 7%). During the follow-up period, the best corrected visual acuity occurred after first PDT in 24 eyes (80%), after second PDT in 5 eyes (16.7%), and after third PDT in 1 eye (3.3%). Conclusions In patients undergone repetitive PDT, CNV in most of the affected eyes completely or partly closed and the visual acuity improved or remained still in 67.8% of the patients in the final follow-up examination. The best correct visual acuity mainly happened after the first PDT, and as the times of PDT increased, the probability of the best correct visual acuity decreased.
机构地区 北京医院眼科
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2006年第4期220-223,共4页 Chinese Journal of Ocular Fundus Diseases
关键词 黄斑变性/治疗 脉络膜新生血管化/治疗 光化学疗法 Photodynamic therapy Macular degeneration/therapy Choroldal neovascularization/therapy
  • 相关文献

参考文献13

  • 1Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with vertePorfin:one-year results of 2randomized clinical trials-TAP report 1.Arch Ophthalmol,1999,117:1329-1345.
  • 2Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:two-year results of 2randomized clinical trials-TAP report 2.Arch Ophthalmol,2001,119:198-207.
  • 3Japanese Age related Macular Degeneration Trial Study Group.One-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.Am J Ophthalmol,2003,131:1049-1061.
  • 4严密,陆方,张军军,孟丹,杜彩凤.光动力疗法治疗渗出型老年性黄斑变性的初步报告[J].中华眼底病杂志,2000,16(4):213-216. 被引量:44
  • 5何守志,李晓陵,王玮,汤如.光动力疗法治疗老年性黄斑变性合并脉络膜新生血管的临床观察[J].中华眼底病杂志,2002,18(3):171-174. 被引量:23
  • 6张美霞,陆方,严密,张军军,孟丹,杜彩凤,沈齐,王顺清,廖晋英.光动力疗法治疗渗出型老年性黄斑变性四年临床观察总结[J].中华眼底病杂志,2004,20(5):275-279. 被引量:53
  • 7Verteporfin roundtable 2000 and 2001 participants,treatment of age-related macular degeneration with photodynamic therapy(TAP) study group principal investigators,vertiporfin in photodynamic therapy (VIP) study group principal investigators.Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.Retina,2002,22:6-18.
  • 8Verteporfin roundtable participants.Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age related macular degeneration and other causes:update.Retina,2005,25:119-134.
  • 9张力,赵明威,黎晓新,姜燕荣,吕永顺.影响光动力疗法治疗脉络膜新生血管视力预后的多因素分析[J].中华眼底病杂志,2004,20(5):292-294. 被引量:19
  • 10夏群,卢颖毅,喻晓兵,龙力,李洁,戴虹.渗出型老年性黄斑变性患者光动力疗法治疗前后视功能变化[J].中华眼底病杂志,2004,20(5):289-291. 被引量:13

二级参考文献30

  • 1中华医学会眼科学会眼底病学组.老年性黄斑变性临床诊断标准[J].眼底病,1987,3:3-3.
  • 2陆方,中华眼底病杂志,2000年,16卷,136页
  • 3中华医学会眼科学会眼底病学组,眼底病,1987年,3卷,F3页
  • 4Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy
  • 5Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for
  • 6Bressler SB, Pieramici DJ, Koester JM, et al. Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to
  • 7Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analy
  • 8Treatment of age-related macular degeneration with photodynamic therapy(TAP) study group.Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin.Arch Ophthalmol,1999,117:1329-1345.
  • 9Schmidt-Erfurth U,Mitler JW,Sichenberg M,et al.Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related degeneration.Arch Ophthalmol,1999,117:1177-1187.
  • 10Macular Photocogulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Arch Ophthalmol, 1991, 109: 1242-1257.

共引文献112

同被引文献62

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部